PathCentral Receives $10,000,000 Series B Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    213 Technology Dr. Irvine, CA 92629
  • Company Description
    PathCentral is the first and only company to provide all the tools required by community pathology practices to increase revenues, improve operating efficiencies, and ensure patient safety, in a single integrated and affordable platform.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series B
  • Proceeds Purposes
    The proceeds will be used to support the company’s growth initiatives, continue to enhance its web-based laboratory information system (LIS), deploy a field sales force, and build out its esoteric cancer diagnostics laboratory.
  • M&A Terms
  • Venture Investor
    Okapi Venture Partners
  • Venture Investor
    Arboretum Ventures
  • Venture Investor
    Baird Venture Partners

Trending on Xconomy